会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Process for producing 3',5'-cyclic adenylic acid
    • 制备3 {40,5 {40-环腺苷酸
    • US4028184A
    • 1977-06-07
    • US673067
    • 1976-04-02
    • Jiro IshiyamaMotohiko KatoFumihiko YoshidaTamotsu Yokotsuka
    • Jiro IshiyamaMotohiko KatoFumihiko YoshidaTamotsu Yokotsuka
    • C12P19/32C12D13/06
    • C12P19/32Y10S435/803Y10S435/822Y10S435/83Y10S435/843
    • A process for producing 3',5'-cyclic adenylic acid in a high yield at a lower price by culturing a strain belonging to the genus selected from the group consisting of Corynebacterium, Arthrobacter and Microbacterium such as, for example, Corynebacterium murisepticum No. 7-10 (ATCC 21977), Arthrobacter 11-211 (ATCC 21978) Microbacterium No. 205-CM7 (ATCC 21979), Microbacterium No. 205-CM-XA3 (ATCC 21980), or Microbacterium No. 205-MP-197 (ATCC 21976) in a medium containing nutrient sources such as, carbon sources, nitrogen sources, inorganic salts and the like but containing no precursors and having a pH of 5-9 at a temperature of 20.degree.-40.degree. C under aerobic condition. The obtained 3',5'-cyclic adenylic acid is well-known for its participation in various biochemical reactions in vivo and for its active role as a mediator to various hormones. It has therefore always been highly evaluated biochemical reagent.
    • 通过培养属于选自棒状杆菌属,节杆菌属和微杆菌属的菌株,例如例如鼠尾草杆菌(Corynebacterium murisepticum No.),以较低的价格生产3',5'-环腺嘌呤酸的方法,以较低的价格生产。 7-10(ATCC 21977),节节杆菌11-211(ATCC 21978)细菌杆菌205-CM7(ATCC 21979),细菌细菌编号205-CM-XA3(ATCC 21980)或微杆菌205-MP-197( ATCC 21976)在含有营养源如碳源,氮源,无机盐等的培养基中,但不含前体,在需氧条件下,在20℃-40℃下pH为5-9。 获得的3',5'-环腺苷酸因其在体内参与各种生物化学反应以及作为各种激素介导物的活性而众所周知。 因此,它一直被高度评价生化试剂。
    • 4. 发明授权
    • Apparatus for connecting external leads
    • 用于连接外部引线的装置
    • US4887758A
    • 1989-12-19
    • US302473
    • 1989-01-26
    • Yasunobu SuzukiMotohiko KatoAkio BandoHisao IshidaAkihiro Nishimura
    • Yasunobu SuzukiMotohiko KatoAkio BandoHisao IshidaAkihiro Nishimura
    • H01L21/60H01L21/00
    • H01L21/67138H01L24/97H01L2224/50
    • An apparatus for connecting or bonding leads of solid-state devices to lead frames, etc. in which a solid-state device punched out of a film carrier by a punch is first picked up and held by a suction-adhesion head. A raising and lowering arm is then driven longitudinally and laterally so that the suction-adhesion head with the solid-state device thereon is moved to a position over a first bonding station. Then, the raising and lowering arm is lowered via a vertical driving mechanism, and the solid-state device held by the suction-adhesion head is pressed against a specified lead frame. A first bonding tool is lowered and simultaneously bonds the leads on two opposite sides of the solid-state device to the lead frame. Then, the first bonding tool is raised, and the suction-adhesion head is raised and moves back to a position over the punch. The lead frame to which two sides of the solid-state device have been thus bonded is fed, and at a second bonding position, the leads on the other two opposite sides of the solid-state device are bonded to the lead frame by a second bonding tool.
    • 用于将固态器件的引线连接或接合到引线框架等的装置,其中通过冲头从薄膜载体冲出的固态装置首先由吸附粘合头拾起并保持。 然后将升降臂纵向和横向地驱动,使得其上具有固态装置的吸附粘合头移动到第一粘结台上方的位置。 然后,升降臂通过垂直驱动机构降低,由吸附粘合头保持的固态装置压靠指定的引线框架。 第一接合工具被降低并且同时将固态器件的两个相对侧上的引线键合到引线框架。 然后,第一接合工具被升高,并且吸附粘合头被升高并且移回到冲头上方的位置。 馈送固态器件的两侧的引线框架,并且在第二接合位置,固态器件的另外两个相对侧上的引线被连接到引线框架上 粘接工具。
    • 9. 发明授权
    • N.sup.6,N.sup.6 -disubstituted-cyclic adenosine-3',5'-monophosphates and
pharmacutical compositions
    • N6,N6-二取代 - 环腺苷-3',5'-单磷酸酯和药物组合物
    • US5246922A
    • 1993-09-21
    • US571188
    • 1990-08-23
    • Shigehiro KataokaNobuyuki YamajiMotohiko KatoShoichi Imai
    • Shigehiro KataokaNobuyuki YamajiMotohiko KatoShoichi Imai
    • C07H19/213A61K31/70A61K31/7042A61K31/7052A61K31/7076A61P9/04C07H19/20
    • C07H19/20Y02P20/55
    • The present invention relates to a N.sup.6,N.sup.6 -disubstituted-cyclic adenosine-3',5'-monophosphate represented by the formula ##STR1## wherein R represents a linear alkyl group having 3 or more carbon atoms or a branched alkyl group having 4 or more carbon atoms, an aralkyl group or an alkenyl group; A.sup..sym. represents a hydrogen ion, an alkali metal ion, an alkaline earth metal ion, an ammonium ion or an organoammonium ion, or a salt thereof, and a cardiac composition comprising it as an effective component, and further includes a process for preparing a compound represented by the formula ##STR2## wherein R.sub.1 represents an alkyl group, an aralkyl group or an alkenyl group and A.sup..sym. has the same meanings as defined above, or a salt thereof, characterized in that a 2'-O-protected-cyclic adenosine-3',5'-monophosphate represented by the formula ##STR3## wherein Y represents a protecting group and A.sup..sym. has the same meanings as defined above, or a salt thereof is reacted with an organic halide represented by the formulaR.sub.1 X (III) wherein X represents a halogen atom and R.sub.1 has the same meanings as defined above, and the protecting group is then removed.
    • 本发明涉及由式(I)表示的N6,N6-二取代环腺苷-3',5'-单磷酸酯,其中R表示具有3个或更多个碳原子的直链烷基或支链烷基 具有4个或更多个碳原子,芳烷基或烯基; A(+)表示氢离子,碱金属离子,碱土金属离子,铵离子或有机铵离子或其盐,以及包含其作为有效成分的心脏组合物,还包括 制备由式(I')表示的化合物,其中R 1表示烷基,芳烷基或烯基,A(+)具有与上述相同的含义或其盐,其特征在于, 或其盐,其中Y表示保护基,A(+)与上述相同的含义,由式(II)表示的2'-O-保护环腺苷-3',5'-单磷酸 与式R1X(III)表示的有机卤化物反应,其中X表示卤素原子,R 1具有与上述相同的含义,然后除去保护基。